BRCA1 and breast cancer: In our cohort, carriers who presented a BRCA1 variant, regardless of what was the other pathogenic variant gene, developed BC at earlier ages (44.7% ≤ 40 years of age; p = 0.022) and were associated with a higher risk for multiple primary tumors when compared with carriers of other gene variants (Figure 2B).